Arrowhead Pharmaceuticals, Inc.ARWRNASDAQ
Loading
Research and development spending
3Y CAGR
+22.4%/yr
vs +44.5%/yr prior
5Y CAGR
+25.7%/yr
Recent deceleration
Acceleration
-22.1pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
3.1x
Strong expansion
Streak
9 yr
Consecutive growthStrong
| Period | Value | YoY Change |
|---|---|---|
| TTM | $647.36M | +6.6% |
| 2025 | $607.16M | +20.0% |
| 2024 | $505.87M | +43.2% |
| 2023 | $353.19M | +18.8% |
| 2022 | $297.31M | +44.1% |
| 2021 | $206.34M | +60.1% |
| 2020 | $128.88M | +59.0% |
| 2019 | $81.05M | +53.0% |
| 2018 | $52.97M | +4.1% |
| 2017 | $50.90M | - |